Fennec Announces Results of Annual Meeting

RESEARCH TRIANGLE PARK, NORTH CAROLINA -- (Marketwired) -- 06/08/16 -- Fennec Pharmaceuticals Inc. (TSX: FRX)(OTCQB: FENCF) today announced that the nominees listed in the management proxy circular dated May 9, 2016 (the "Circular") for the Annual Meeting of Shareholders were elected as directors of the Company at the Annual Meeting of Shareholders held in Boston, Massachusetts on June 8, 2016 (the "Meeting"). Detailed results of the vote for the election of directors are set out below:

----------------------------------------------------------------------------

Name of Nominee        Votes For % Votes For Votes Withheld % Votes Withheld
----------------------------------------------------------------------------
Dr. Khalid Islam       5,960,408      99.95%          2,856            0.05%
----------------------------------------------------------------------------
Mr. Adrian Haigh       5,960,335      99.95%          2,929            0.05%
----------------------------------------------------------------------------
Mr. Chris A. Rallis    5,960,335      99.95%          2,929            0.05%
----------------------------------------------------------------------------
Mr. Rostislav Raykov   5,960,335      99.95%          2,929            0.05%
----------------------------------------------------------------------------

Contacts:
Fennec Pharmaceuticals Inc.
Rosty Raykov
Chief Executive Officer
(919) 636-5144

Source: Fennec Pharmaceuticals Inc.

You May Also Be Interested In

• Digital Therapeutics Market Size Worth USD 44.13 billion by 2031, to Grow at a CAGR of 31.02% | As per SNS Insider
• Jessup House Provides Perfect Backdrop for Philadelphia Life
• Keep Up with Kitchen Trends